With an estimated two billion people affected worldwide, fatty liver disease is a silent epidemic that often goes unnoticed until it’s too late. Learn the crucial early warning signs that could help ...

Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR ) and its oncology-focused subsidiary, Citius Oncology (Nasdaq: CTOR ), today announced significant progress in ...

U.S. Sen. Debbie Stabenow and Eastern Market Partnership CEO Dan Carmody started 2024 at President Joe Biden’s State of the Union speech in Washington and ended the year appearing on CBS Detroit’s ...

New York Giants President and CEO John Mara talks about the decision to retain head coach Brian Daboll and GM Joe Schoen.

Adds an additional commercial and strategic rare disease product to Eton’s portfolioGalzin is FDA-approved for the treatment of the ultra-rare ...

SXSW EDU® is excited to unveil the list of finalists for its 2025 Launch Startup Competition and Student Impact Challenge . This year's selected cohorts represent teams from the United States, Brazil, ...

Bilirubin-induced neurologic dysfunction can occur in term and late-preterm healthy babies, however, can be effectively prevented through rapid reduction of the increased bilirubin load by ...

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

Conjugation of bilirubin and delivery to the intestine doesn't necessarily lead to excretion of the substance. Neonatal intestines contain beta-glucuronidase, an enzyme capable of reducing ...

In any case, new support levels are usually revised to the database at the beginning of the next trading session. Short BILI slightly under 18.07, target n/a, stop loss @ 18.12 Details The technical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...